380.73
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HUM Giù?
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$378.02
Aprire:
$374.29
Volume 24 ore:
1.32M
Relative Volume:
0.96
Capitalizzazione di mercato:
$45.72B
Reddito:
$137.20B
Utile/perdita netta:
$1.15B
Rapporto P/E:
40.75
EPS:
9.3439
Flusso di cassa netto:
$1.27B
1 W Prestazione:
-1.10%
1M Prestazione:
-4.39%
6M Prestazione:
+100.56%
1 anno Prestazione:
+31.29%
Humana Inc Stock (HUM) Company Profile
Nome
Humana Inc
Settore
Industria
Telefono
(502) 580-1000
Indirizzo
101 E. MAIN STREET, LOUISVILLE, KY
Compare HUM vs UNH, CVS, ELV, CI
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
HUM
Humana Inc
|
380.73 | 45.39B | 137.20B | 1.15B | 1.27B | 9.3439 |
|
UNH
Unitedhealth Group Inc
|
384.85 | 348.81B | 450.13B | 14.91B | 23.62B | 15.55 |
|
CVS
Cvs Health Corp
|
93.65 | 119.78B | 407.94B | 2.90B | 7.39B | 2.2771 |
|
ELV
Elevance Health Inc
|
396.28 | 86.41B | 201.11B | 4.95B | 6.29B | 22.50 |
|
CI
Cigna Group
|
274.41 | 73.31B | 278.13B | 6.74B | 7.66B | 23.60 |
Humana Inc Stock (HUM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-12 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-02-02 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2026-01-07 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2025-12-05 | Aggiornamento | Jefferies | Hold → Buy |
| 2025-10-14 | Iniziato | Goldman | Sell |
| 2025-09-22 | Iniziato | Evercore ISI | In-line |
| 2025-05-01 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2024-11-06 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2024-10-11 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2024-10-08 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2024-10-07 | Downgrade | Jefferies | Buy → Hold |
| 2024-10-07 | Downgrade | TD Cowen | Buy → Hold |
| 2024-10-03 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-10-02 | Downgrade | BofA Securities | Neutral → Underperform |
| 2024-10-02 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-10-02 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2024-06-26 | Iniziato | Piper Sandler | Overweight |
| 2024-06-24 | Iniziato | Morgan Stanley | Equal-Weight |
| 2024-04-02 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-03-22 | Iniziato | Raymond James | Mkt Perform |
| 2024-03-13 | Downgrade | Argus | Buy → Hold |
| 2024-03-06 | Iniziato | Barclays | Equal Weight |
| 2024-01-26 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2024-01-25 | Downgrade | Deutsche Bank | Buy → Hold |
| 2023-12-12 | Aggiornamento | Argus | Hold → Buy |
| 2023-11-08 | Downgrade | BofA Securities | Neutral → Underperform |
| 2023-07-07 | Downgrade | JP Morgan | Overweight → Neutral |
| 2023-06-23 | Downgrade | Argus | Buy → Hold |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-12-13 | Aggiornamento | Goldman | Neutral → Buy |
| 2022-10-26 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2022-09-20 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-06-17 | Iniziato | Loop Capital | Buy |
| 2022-05-27 | Iniziato | Bernstein | Mkt Perform |
| 2022-04-13 | Aggiornamento | UBS | Neutral → Buy |
| 2022-01-06 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2021-12-16 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-14 | Iniziato | Goldman | Neutral |
| 2021-11-04 | Reiterato | Barclays | Overweight |
| 2021-11-04 | Reiterato | Credit Suisse | Outperform |
| 2021-11-04 | Reiterato | Morgan Stanley | Overweight |
| 2021-11-04 | Reiterato | Oppenheimer | Outperform |
| 2021-11-04 | Reiterato | RBC Capital Mkts | Outperform |
| 2021-09-27 | Iniziato | SVB Leerink | Outperform |
| 2021-09-10 | Iniziato | Cowen | Outperform |
| 2021-09-09 | Ripresa | Barclays | Overweight |
| 2021-07-09 | Iniziato | Seaport Global Securities | Neutral |
| 2021-05-19 | Iniziato | Wells Fargo | Equal Weight |
| 2021-01-04 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-10-02 | Iniziato | Bernstein | Mkt Perform |
| 2020-07-01 | Iniziato | SVB Leerink | Outperform |
| 2020-06-16 | Downgrade | Cowen | Outperform → Market Perform |
| 2020-06-05 | Iniziato | Goldman | Buy |
| 2020-01-03 | Reiterato | JP Morgan | Overweight |
| 2019-10-18 | Iniziato | Mizuho | Buy |
| 2019-09-30 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2019-09-12 | Iniziato | Deutsche Bank | Hold |
| 2019-08-12 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2019-04-23 | Iniziato | UBS | Neutral |
| 2019-01-14 | Iniziato | Stephens | Overweight |
| 2018-12-20 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-11-08 | Reiterato | BofA/Merrill | Buy |
| 2018-09-13 | Iniziato | Barclays | Overweight |
| 2018-07-12 | Ripresa | Morgan Stanley | Overweight |
| 2018-07-06 | Reiterato | Piper Jaffray | Overweight |
| 2018-06-01 | Ripresa | Citigroup | Buy |
| 2018-02-08 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2018-02-08 | Reiterato | Leerink Partners | Outperform |
| 2018-01-12 | Aggiornamento | Jefferies | Hold → Buy |
Mostra tutto
Humana Inc Borsa (HUM) Ultime notizie
Can Humana's Star Ratings Rebound Unlock MA Earnings Power? - TradingView
Humana names Shantanu Nundy as chief medical officer - Investing.com
Humana names a practicing doctor to help shape its products and AI - Stock Titan
Humana Names Dr. Shantanu Nundy as Chief Medical Officer - Business Wire
Tocqueville Asset Management L.P. Buys Shares of 66,567 Humana Inc. $HUM - MarketBeat
Deutsche Bank AG Purchases New Stake in Humana Inc. $HUM - MarketBeat
Danske Bank A S Purchases New Position in Humana Inc. $HUM - MarketBeat
First National Bank of Omaha Takes Position in Humana Inc. $HUM - MarketBeat
Why Is Humana (NYSE:HUM) CenterWell Expansion in Focus After Q2? - Kalkine Media
Humana Inc. stock outperforms competitors despite losses on the day - MarketWatch
UnitedHealth Stock Looks Reasonable at 18.39X P/E: Should You Buy Now? - TradingView
290,935 Shares in Humana Inc. $HUM Acquired by Mitsubishi UFJ Asset Management Co. Ltd. - MarketBeat
Humana Inc. $HUM Shares Sold by Handelsbanken Fonder AB - MarketBeat
BlackRock Inc. Takes Position in Humana Inc. $HUM - MarketBeat
4,403,136 Shares in Humana Inc. $HUM Acquired by Pzena Investment Management LLC - MarketBeat
Humana (NYSE:HUM) Home Care Push Puts Valuation In Focus - Kalkine Media
Humana Inc. (HUM) Stock Analysis: Exploring a 7% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Diamond Hill Capital Management LLC Investment Advisor Makes New Investment in Humana Inc. $HUM - MarketBeat
Law firm investigates Humana directors for poss... - Pluang
Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PR Newswire
7,351 Shares in Humana Inc. $HUM Purchased by S&CO Inc. - MarketBeat
Glenmark USA Agrees to USD 15.28 Mn Settlement With Humana Over Generic Drug Antitrust Claims - Medical Dialogues
Humana Stock Gains 1.1% as 600,000-Member Medicare Reset Tests Its 2028 Margin Plan - TechStock²
Oppenheimer Asset Management Inc. Makes New $9.05 Million Investment in Humana Inc. $HUM - MarketBeat
BlackRock Event Driven Equity Fund's Humana Inc(HUM) Holding History - GuruFocus
Humana Inc. stock outperforms competitors on strong trading day - MarketWatch
Brokers Set Expectations for Humana's Q3 Earnings (NYSE:HUM) - MarketBeat
Do Wall Street Analysts Like Humana Stock? - Barchart.com
Mirae Asset Global Investments Co. Ltd. Acquires 3,726 Shares of Humana Inc. $HUM - MarketBeat
3,146 Shares in Humana Inc. $HUM Purchased by Retireful LLC - MarketBeat
TriaGen Wealth Management LLC Purchases New Stake in Humana Inc. $HUM - MarketBeat
Humana Inc. $HUM Shares Sold by Cetera Investment Advisers - MarketBeat
Glenmark Will Pay $15.3M To End Humana's Price-Fixing Claims - Law360
CPI | Glenmark to Pay $15.3 Million to Settle Humana Antitrust Claims - PYMNTS.com
Can Humana Improve Caregiver Retention With HealthStream Deal? - The Globe and Mail
Equities Analysts Offer Predictions for Humana Q1 Earnings - MarketBeat
Humana (NYSE:HUM) Downgraded by Zacks Research to "Hold" - MarketBeat
Humana stock (HUM) climbs 3% as 2027 COLA calculations obscure rising medical-cost shortfall - TechStock²
Why Is Humana (NYSE:HUM) Betting Bigger on Medicaid and CenterWell? - Kalkine Media
Humana names new Medicaid president - The Business Journals
Medicare Will Spend More Than $13 Billion on the Medicare Advantage Quality Bonus Program in 2026 - KFF
Humana Inc. (HUM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Humana Inc (HUM) Stock Down 3.3% but Still Overvalued -- GF Scor - GuruFocus
Glenmark settles Humana antitrust lawsuit for $15.28 million - scanx.trade
Glenmark Pharma US arm agrees to $15.28 million settlement with Humana over antitrust lawsuits - CNBC TV18
Humana taps ex-Johns Hopkins exec as Medicaid leader - Healthcare Dive
Humana Healthy Horizons in Indiana Collaborates with HealthStream to Expand and Strengthen Home Care Workforce - Business Wire
James P. Holland to Join Humana as Medicaid President - Humana
Humana Names James P. Holland President of Medicaid - citybiz
Humana appoints James Holland to lead Medicaid business - Investing.com
Humana’s Incoming Medicaid President Will Lead Business in 11 States - Stock Titan
Humana Inc Azioni (HUM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):